BioPharma Credit PLC UPDATE ON INVESTMENT
28 May 2024 - 5:11PM
RNS Regulatory News
RNS Number : 0768Q
BioPharma Credit PLC
28 May 2024
28 May 2024
BIOPHARMA
CREDIT PLC
UPDATE ON
INVESTMENT
BioPharma Credit PLC (LSE:
BPCR) notes the update on the UK CMA (Competition and Markets
Authority) website made on 24 May 2024 regarding the
status of its review of the acquisition of LumiraDx by Roche.
The updated website can be found in its entirety
at: UK
CMA Roche / LumiraDx merger inquiry.
The acquisition of LumiraDx by Roche
continues to undergo the standard process to receive antitrust and
regulatory reviews. At this time, Pharmakon Advisors, LP
cannot comment beyond what has been made public by the CMA and the
companies involved in the transaction.
Pharmakon Advisors, LP is continuing
to actively monitor the situation and will provide any updates in
due course.
Enquiries
Buchanan
David Rydell / Mark Court
/ Jamie Hooper / Henry Wilson
+44 (0) 20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors
BioPharma Credit
PLC is London's only specialist debt investor to the
life sciences industry and joined the LSE in March
2017. BioPharma Credit PLC seeks to provide long-term
shareholder returns, principally in the form of sustainable income
distributions from exposure to the life sciences
industry. BioPharma Credit PLC seeks to achieve this
objective primarily through investments in debt assets secured by
royalties or other cash flows derived from the sales of approved
life sciences products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
UPDAPMRTMTMTMRI
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2024 to Jun 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Jun 2023 to Jun 2024